Journals / Fırat Tıp Dergisi / 2014 / Cilt: 19 - Sayı: 1

Alternative Pathways in the Pathophysiology of Priapism

Priapizm Patofizyolojisinde Alternatif Yolaklar

Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the present study, the experimental data related to the pathways that play an active role in the pathophysiology of priapism and its reflections on the practice were evaluated

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Priapism is described as the extended unpreferred erection status without any sexual stimulus.
📊
Key Findings & Data:Recently, it was shown in experimental priapism models that adenosine and hemoxygenase-1carbonmonoxide (HO1-CO) are effective in the development of recurrent priapism attacks.
💡
Conclusion & Impact:In the present study, the experimental data related to the pathways that play an active role in the pathophysiology of priapism and its reflections on the practice were evaluated
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Priapism is described as the extended unpreferred erection status without any sexual stimulus. There are three types of priapism which are classified as ischemic, non ischemic and recurrent priapism depending on the blood flow of the penile artery. Ischemic priapism is a real urological emergency which requires urgent and appropriate approach. Recently, it was shown in experimental priapism models that adenosine and hemoxygenase-1carbonmonoxide (HO1-CO) are effective in the development of recurrent priapism attacks. Moreover, it was reported that dysregulated PDE-5 activity, decreased Norepinephrine response and altered Endothelin receptor activity may be effective in the pathophysiology of priapism. In the present study, the experimental data related to the pathways that play an active role in the pathophysiology of priapism and its reflections on the practice were evaluated

Özet

Priapizm, cinsel uyarı olmaksızın uzamış istenmeyen ereksiyon halidir. Priapizmin penil arter kan akımına bağlı olarak iskemik, non iskemik ve tekrarlayan olmak üzere üç tipi vardır. İskemik priapizm hızlı ve doğru yaklaşım gerektiren gerçek ürolojik bir acildir. Son yıllarda özellikle adenozin ve hemoksijenaz 1-karbonmonoksit'in tekrarlayan priapizm ataklarında etkin olduğu deneysel modellerde belirlenmiştir. Ayrıca priapizm patofizyolojisinde disregüle PDE5 aktivitesi, azalmış Norepinefrin cevabı ve Endotelin-1'in değişen reseptör aktivitesinin de etkin olabileceği bildirilmektedir. Bu çalışmada, priapizm patofizyolojisinde etkin rol oynayan yolaklarla ilgili deneysel veriler ve klinik yansımaları değerlendirildi

🔖

Cite This Article

KARAKEÇİA, A. (2014). Alternative Pathways in the Pathophysiology of Priapism. Fırat Tıp Dergisi, Cilt: 19 - Sayı: 1, 1–5. https://ajindex.com/articles/210835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Pryor J, Akkus E, Alter G, et al. Priapism. J Sex Med 2004; 1: 116-20
  2. Broderick GA, Harkaway R. Pharmacologic erection: timedependent changes in the corporal environment. Int J Impot Res 1994; 6: 9-16
  3. Muneer A, Cellek S, Doğan A, et al. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Import Res 2005; 17: 10-8
  4. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986; 135: 142-7
  5. Cherian J, Rao AR, Thwaini A, et al. Medical and surgical management of priapism. Postgrad Med J 2006; 82: 89-94
  6. Ozan T, Fırdolaş F, Orhan İ. Deneysel Çalışmalarda Priapizm: Kliniğe Yansımalar. Turk Urol Sem 2011; 2: 281-7
  7. Ul-Hasan M, El-Sakka AI, Lee C, et al. Expression of TGFbeta 1 m-RNA and ultrastructural alterations in pharmacologically indu-ced prolonged penile erection in a canine model. J Urol 1998; 160: 2263-6
  8. Sanli O, Armagan A, Kandirali E, et al. TGF-beta1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 2004; 16: 492-7
  9. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. J Urol 2003; 170: 1318-24
  10. Teng RB, Zhang XH. Oxytocin and male sexual function. Zhonghua Nan Ke Zue 2011; 17: 558-61
  11. Burnet A, Tillman SL, Chang TS, et al. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol 1993; 150: 73-6
  12. Claudino MA, Franco-Penteado CF, Priviero FB, et al. Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training. Urology 2010; 75: 961-7
  13. Phatarpekar PV, Wen J, Xia Y. Role of adenosine signaling in penile erection and erectile disorders. J Sex Med 2010; 7: 3553-64
  14. Patole S, Lee J, Buettner P, et al. Improved oxygenation following adenosine infusion in persistent pulmonary hypertension of the newborn. Biol Neonate 1998; 74: 345-50
  15. Tiejuan Mi, Shahrzad Abbasi, Hong Zhang, et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008; 118: 1491-501
  16. Filippi S, Mancini M, Amerini S, et al. Functional adenosine receptors in human corpora cavernosa. Int J Androl 2000; 23: 210-7
  17. Chiang PH, Wu SN, Tsai EM, et al. Adenosine modulation of neurotransmission in penile erection